🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vinay K Rathi

Columbus State University

ORCID: 0000-0002-9763-9075

Also affiliated with Center for Innovation, The Ohio State University

Economics, Econometrics and FinanceMedicinePharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018”.

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018

BMJ Surgery, Interventions, & Health Technologies(2023)10.1136/bmjsit-2022-000152
N/A
0.165DataRank · unranked
2 citations

James L Johnston, Sanket S. Dhruva, Joseph Ross, Vinay K Rathi

Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019

JAMA Internal Medicine(2020)10.1001/jamainternmed.2020.3214
N/A
0DataRank · unranked
26 citations

Sanket S. Dhruva, Joseph S. Ross, Vinay K Rathi, James L. Johnston

Clinical Evidence Supporting FDA Clearance of First-of-a-Kind Therapeutic Devices via the De Novo Pathway Between 2011 and 2019

medRxiv(2020)10.1101/2020.04.23.20077164
N/A
0DataRank · unranked
3 citations

Sanket S. Dhruva, Joseph S. Ross, Vinay K Rathi, James L. Johnston

Adverse events associated with budesonide nasal irrigation reported to the US Food and Drug Administration: 2007 to 2022

International Forum of Allergy & Rhinology(2023)10.1002/alr.23232
N/A
0DataRank · unranked
1 citations

Nicholas Sawicki, Rodney J. Schlosser, Zachary M. Soler, George A. Scangas, Alan D. Workman +2 more

The Inflation Reduction Act: Implications for Medicare spending and access to biologic therapies for chronic rhinosinusitis with nasal polyposis and asthma

International Forum of Allergy & Rhinology(2024)10.1002/alr.23344
N/A
0DataRank · unranked
8 citations

Zachary M. Soler, Rodney J. Schlosser, Alan D. Workman, Nikita Chapurin, Nicholas R. Rowan +2 more

Nonconcurrent Control Use in FDA Approval of High-Risk Medical Devices

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.6230
N/A
0DataRank · unranked
4 citations

Sanket S. Dhruva, Hollin R.L. Hakimian, Vinay K Rathi, Kushal T. Kadakia, Joseph S. Ross +1 more

FDA Recalls of Image Guidance Systems for Sinus and Skull Base Surgery, 2003–2024

International Forum of Allergy & Rhinology(2025)10.1002/alr.23590
N/A
0DataRank · unranked
0 citations

Rodney J. Schlosser, Zachary M. Soler, Patrick C. Walz, Kyle C. Wu, Ralph Metson +4 more